Shanmiao Gou

2.2k total citations · 1 hit paper
58 papers, 1.7k citations indexed

About

Shanmiao Gou is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Shanmiao Gou has authored 58 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 26 papers in Surgery and 18 papers in Molecular Biology. Recurrent topics in Shanmiao Gou's work include Pancreatic and Hepatic Oncology Research (30 papers), Pancreatitis Pathology and Treatment (15 papers) and Gastrointestinal disorders and treatments (8 papers). Shanmiao Gou is often cited by papers focused on Pancreatic and Hepatic Oncology Research (30 papers), Pancreatitis Pathology and Treatment (15 papers) and Gastrointestinal disorders and treatments (8 papers). Shanmiao Gou collaborates with scholars based in China, United States and Canada. Shanmiao Gou's co-authors include Chunyou Wang, Heshui Wu, Tao Yin, Jiongxin Xiong, Pengfei Shi, Tao Liu, Zhiqiang Liu, Shihong Wu, Yongfeng Li and Jingyuan Zhao and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Shanmiao Gou

53 papers receiving 1.6k citations

Hit Papers

Prognostic accuracy of the serum lactate level, the SOFA ... 2019 2026 2021 2023 2019 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shanmiao Gou China 26 752 741 402 318 284 58 1.7k
Christian Garbar France 24 448 0.6× 419 0.6× 291 0.7× 168 0.5× 309 1.1× 75 1.9k
Yao‐Li Chen Taiwan 23 419 0.6× 315 0.4× 407 1.0× 232 0.7× 330 1.2× 101 1.5k
Kun‐Chun Chiang Taiwan 27 598 0.8× 612 0.8× 522 1.3× 315 1.0× 168 0.6× 101 2.0k
John Wang United States 22 519 0.7× 314 0.4× 250 0.6× 221 0.7× 287 1.0× 81 1.4k
Sinéad Toomey Ireland 19 714 0.9× 494 0.7× 234 0.6× 243 0.8× 236 0.8× 66 2.0k
Håkon Reikvam Norway 32 1.3k 1.8× 517 0.7× 169 0.4× 339 1.1× 227 0.8× 180 3.0k
Chunli Shao China 16 619 0.8× 442 0.6× 212 0.5× 205 0.6× 302 1.1× 58 1.6k
Ruiming Rong China 28 884 1.2× 231 0.3× 339 0.8× 254 0.8× 225 0.8× 103 2.2k
Lauren N. Bell United States 19 653 0.9× 516 0.7× 155 0.4× 380 1.2× 420 1.5× 25 1.9k

Countries citing papers authored by Shanmiao Gou

Since Specialization
Citations

This map shows the geographic impact of Shanmiao Gou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shanmiao Gou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shanmiao Gou more than expected).

Fields of papers citing papers by Shanmiao Gou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shanmiao Gou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shanmiao Gou. The network helps show where Shanmiao Gou may publish in the future.

Co-authorship network of co-authors of Shanmiao Gou

This figure shows the co-authorship network connecting the top 25 collaborators of Shanmiao Gou. A scholar is included among the top collaborators of Shanmiao Gou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shanmiao Gou. Shanmiao Gou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Yuhan, Xueyi Liang, Haixin Yu, et al.. (2025). BAP1 Represses Sequential Activation of IRAKs and NF-κB Signaling in Pancreatic Cancer. International Journal of Biological Sciences. 21(5). 1949–1965.
2.
Chen, Taoyu, Haixin Yu, Keshan Wang, et al.. (2025). HDAC5 deficiency induces intrinsic resistance to KRAS inhibition by disrupting c-Myc acetylation-ubiquitination homeostasis. Journal of Clinical Investigation. 136(3). 1 indexed citations
3.
Qin, Jiaqi, Jingjie Liu, Zhaohan Wei, et al.. (2024). Targeted intervention in nerve–cancer crosstalk enhances pancreatic cancer chemotherapy. Nature Nanotechnology. 20(2). 311–324. 26 indexed citations
4.
Sun, Ying, Yongfeng Li, Zhiqiang Liu, et al.. (2024). Stent placement for the prevention of clinically-relevant postoperative pancreatic fistula following pancreaticojejunostomy: A systematic review and meta-analysis. The American Journal of Surgery. 234. 122–128. 3 indexed citations
5.
Cui, Jing, Yao Guo, Tao Yin, et al.. (2023). USP8 promotes gemcitabine resistance of pancreatic cancer via deubiquitinating and stabilizing Nrf2. Biomedicine & Pharmacotherapy. 166. 115359–115359. 14 indexed citations
7.
Wei, Jishu, Qiang Xu, Yuhua Zhang, et al.. (2022). Digestive tract reconstruction in pancreaticoduodenectomy in University Hospitals of China: a national questionnaire survey. SHILAP Revista de lepidopterología. 5(4). 151–158.
8.
Li, Yongfeng, Zhiqiang Liu, Yushun Zhang, et al.. (2016). Implantation of radioactive 125I seeds improves the prognosis of locally advanced pancreatic cancer patients: A retrospective study. Journal of Huazhong University of Science and Technology [Medical Sciences]. 36(2). 205–210. 8 indexed citations
9.
Zhao, Gang, Shanmiao Gou, Jiongxin Xiong, et al.. (2015). Etiology, pathology, management and prognosis of chronic pancreatitis in Chinese population: A retrospective study. Journal of Huazhong University of Science and Technology [Medical Sciences]. 35(3). 384–389. 3 indexed citations
10.
Li, Li, Ling Yan, Min Huang, et al.. (2015). Heparin inhibits the inflammatory response induced by LPS and HMGB1 by blocking the binding of HMGB1 to the surface of macrophages. Cytokine. 72(1). 36–42. 46 indexed citations
11.
Gou, Shanmiao, Zhiyong Yang, Tao Liu, Heshui Wu, & Chunyou Wang. (2014). Use of probiotics in the treatment of severe acute pancreatitis: a systematic review and meta-analysis of randomized controlled trials. Critical Care. 18(2). R57–R57. 60 indexed citations
12.
Zhou, Feng, Shanmiao Gou, Jiongxin Xiong, et al.. (2014). Surgical treatment of chronic pancreatitis in young patients. Journal of Huazhong University of Science and Technology [Medical Sciences]. 34(5). 701–705. 1 indexed citations
13.
Yang, Chong, Heshui Wu, Xinglin Chen, et al.. (2014). Pylorus-Preserving Versus Pylorus-Resecting Pancreaticoduodenectomy for Periampullary and Pancreatic Carcinoma: A Meta-Analysis. PLoS ONE. 9(3). e90316–e90316. 30 indexed citations
14.
Shi, Pengfei, Tao Yin, Feng Zhou, et al.. (2014). Valproic acid sensitizes pancreatic cancer cells to natural killer cell-mediated lysis by upregulating MICA and MICB via the PI3K/Akt signaling pathway. BMC Cancer. 14(1). 370–370. 55 indexed citations
16.
Yin, Tao, Zhiyong Yang, Shanmiao Gou, et al.. (2011). Bmi-1 Promotes the Chemoresistance, Invasion and Tumorigenesis of Pancreatic Cancer Cells. Chemotherapy. 57(6). 488–496. 33 indexed citations
17.
Zhou, Wei, Li Wang, Shanmiao Gou, et al.. (2011). ShRNA silencing glycogen synthase kinase-3 beta inhibits tumor growth and angiogenesis in pancreatic cancer. Cancer Letters. 316(2). 178–186. 52 indexed citations
18.
Huang, Peng, et al.. (2008). Isolation and biological analysis of tumor stem cells from pancreatic adenocarcinoma. World Journal of Gastroenterology. 14(24). 3903–3903. 46 indexed citations
19.
Wang, Chunyou, Tao Liu, Heshui Wu, et al.. (2008). Duodenum-preserving total pancreatic head resection without segment resection of the duodenum for chronic pancreatitis. Langenbeck s Archives of Surgery. 394(3). 563–568. 4 indexed citations
20.
Liu, Tao, Chunyou Wang, Shanmiao Gou, et al.. (2007). PDX-1 expression and proliferation of duct epithelial cells after partial pancreatectomy in rats.. PubMed. 6(4). 424–9. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026